GSK Co-Pay program for patients treated with GSK COVID treatment Terms and Conditions

For information on the GSK Co-pay Program, please call the GSK COVID Contact Center at 1-866-GSK-COVID (866-475-2684) or visit the patient website for enrollment information.

Assistance is available in Spanish and many other languages
La asistencia está disponible en español y muchos otros idiomas

GSK Copay program Full Terms and Conditions

Eligibility criteria

Patients may be eligible based on general eligibility criteria below:

  • Have a commercial medical or prescription insurance plan; and
  • Are a resident of the US (including the District of Columbia, Puerto Rico, and the US Virgin Islands); and
  • Are not eligible for or enrolled in a government funded programs

Patients who have insurance coverage provided through any type of state-, federal-, or government funded program (e.g., Medicare, Medicaid, Tricare, VA) are not eligible to participate in the GSK Co-Pay Program. Medicare eligible patients who are enrolled in a government subsidized retiree prescription drug benefit plan or an employer group waiver health plan are also ineligible for the Co-pay program. (Most patients become eligible for Medicare when they reach age 65).

If a patient's drug coverage is provided by a private commercial payer and the commercial payer has opted out of the GSK Co-pay Program, patient is not eligible to participate.

To determine eligibility for the GSK Co-pay Program for COVID Patients, patients must submit an Enrollment Form which is available on The Program will evaluate the patient for eligibility and communicate eligibility to the patient. Patients must have been treated and paid out-of-pocket costs for the GSK Product in order to apply for the GSK Co-pay Program. Claims must be submitted to the Program within 90 days from the date the Explanation of Benefits was issued.

The GSK Co-pay Program is not insurance. GSK reserves the right to rescind, revoke, or amend this offer without notice at any time. Offer good only in the United States (including the District of Columbia, Puerto Rico and the US Virgin Islands). Void where prohibited, taxed, or otherwise restricted by law.

Program Details:

If patients are approved, the GSK Co-pay Program may help with the patient's cost share for the GSK product, and the patient's cost share for administration, up to $100 per administration, up to a program total of $2,000. Residents of Massachusetts, Minnesota or Rhode Island, are not eligible for reimbursement of administrative fees. Doctor's office visits, labs, and other ancillary services are not included in the Co-Pay Program.